Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 11, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 15, 2026
CFOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001683168-26-007158
Filed / recorded
Sep 15, 2026, 8:00 PM UTC
Added to OQRO
Oct 8, 2026, 2:22 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Phio Pharmaceuticals Corp.
Issuer CIK
1533040
Ticker
PHIO
Reporting person
Lisa Cabott Carson
Relationship
Officer
Officer title
Chief Financial Officer
Security
Common Stock, $.0001 par value
Table
Non-derivative (Table I)
Transaction date
Sep 11, 2026
Transaction code
F
Shares / units
12,888
Price per share
$1.03
Acquired / disposed
Disposed (D)
Shares owned after
81,112
Ownership form
Direct
Amendment
No
Footnotes from the filing
The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
Includes shares of common stock underlying unvested restricted stock units.
A Phio Pharmaceuticals director paid $5.2K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 14% with this purchase.
3 insiders in a week, 2nd time since 2013Traded Sep 28 · filed 2 days later
A Phio Pharmaceuticals director paid $5.2K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 16% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Changed a top executive or board member, and held a shareholder vote
“Phio Pharmaceuticals Corp. (the “Company”) held its 2026 Annual Meeting of Stockholders via live webcast (the “Annual Meeting”) on September 28, 2026.”